The Democratic Progressive Party (DPP) yesterday said the Chinese Nationalist Party (KMT) had launched another smear campaign against DPP presidential candidate Tsai Ing-wen (蔡英文) over her involvement in Yu Chang Biologics Co (宇昌生技股份有限公司), saying the KMT’s allegation lacked solid evidence.
The KMT said Tsai received improper benefits from the firm when she served in government, but according to DPP spokesperson Chen Chi-mai (陳其邁), the KMT has purposely chosen to release only partial information and made the allegation purely on speculation.
A pair of declassified documents with Tsai’s signature dating from the time she served as vice premier were provided to the legislature yesterday by Council for Economic Planning and Development (CEPD) Minister Christina Liu (劉憶如) in the presence of several KMT lawmakers and political pundit Clara Chou (周玉蔻).
Photo: Chang Chia-ming, Taipei Times
Academia Sinica President Wong Chi-huey (翁啟惠), one of the scientists who invited Tsai to join Yu Chang, told reporters on Sunday that the controversy has been “unfair” to Tsai.
In a press release yesterday, Wong said Tsai should be commended for her assistance in developing the biotech industry.
Chen Mei-ling (陳美伶), former deputy secretary-general of the Executive Yuan, also told reporters yesterday that Tsai did not violate “revolving door” regulations on public officials because the regulation does not apply to deputies and the biotech industry was not under the scope of Tsai’s supervision at the time.
Chen said the so-called scandal is the result of collaboration between the KMT, its legislators, government officials, some media outlets and political pundits, and comes about a month before the presidential election, which stands to benefit President Ma Ying-jeou’s (馬英九) re-election campaign.
Chen said Liu had failed to maintain her administrative neutrality when she said Tsai had been called a shoo-in as Yu Chang chairperson at an investors’ conference on March 31, 2007, when she was still vice premier.
The KMT said Tsai was guilty of a conflict of interest because of her involvement with Yu Chang after she left office in August 2007 and she later became chairperson of the firm, which received investment from the state-owned National Development Fund (NDF), adding that Tsai had received NT$100 million (then US$3.3 million) when she sold her shares in the company in 2009.
The KMT has questioned Tsai’s role in the case on at least four grounds — investment of Tsai’s family businesses, her position as Yu Chang’s chairperson after leaving office, the classification of related documents as top-secret and suspected profiteering by Tsai and her family.
Tsai was keen on promoting the biotech industry as one of the nation’s strategic sectors when she served as vice premier and did not decide to persuade her family to invest after the start-up failed to attract investors in its initial stage, former CEPD chairperson Ho Mei-yueh (何美玥) said during a press conference.
“The accusation of Tsai wanting to profit from this project is far from the truth. Without the Tsai family’s funding, the company would not have been created in time for the deal,” she said.
Ho added that it was not possible that Tsai paved her way to the position of Yu Chang’s chairperson because she would not have resigned as vice premier if former premier Su Tseng-chang (蘇貞昌) did not step down after losing the DPP primary for the 2008 presidential election.
She decided to keep the document on the establishment of Yu Chang and a bid for Genentech confidential because there were foreign competitors vying for the deal at the time, Ho said.
“The documents were classified as ‘official secret’ — not ‘national secret’ — and could be declassified after the contract was signed,” she said.
Tsai’s resignation as vice premier in May 2007 and her assuming the DPP’s leadership position in May 2008 could have never been planned and that should be enough to eliminate all the conspiracy theories, said Lien Yuan-lung (連元龍), a lawyer representing the DPP, adding that the project was “tailor-made” for Tsai.
Tsai did not say her family would invest in Yu Chang in the official documents nor did her family members attend the investors’ conference, Lien said, adding that Tsai said publicly on Sept. 15, 2007, that her family would withdraw its investment once the project was fully funded.
The NDF’s funding of the company did not bypass the required screening procedures because the NDF approved the funding on April 17, 2007, he said.
The only difference between the funding and other projects, he said, was that it was planned as a “special project” by a top-down decision, the same process as when the Ma administration approved the investment of NT$5 billion in China Airlines in 2009, which posted a NT$3.8 billion loss that year.
In response to accusations by the KMT that Tsai masterminded the passage of the Biotech and New Pharmaceuticals Industry Development Act (生技新藥產業發展條例) in 2007 to help establish Yu Chang, the DPP said that piece of legislation was pushed through by Legislative Speaker Wang Jin-pyng (王金平), who himself has said the act was beneficial to the nation.
According to the legislature’s gazette, Wang played an active role in the enactment and passage of the act and was part of efforts jointly exerted by the legislature, then dominated by the KMT, and executive branches to offer various incentives to boost the sector.
The act was supported by 104 lawmakers, out of a total of 225 seats, across party lines, led by Wang and then-legislative deputy speaker David Chung (鍾榮吉) of the People First Party, marking the first and only time in the nation’s history that a bill was sponsored by the legislative speaker and the deputy speaker.
Sent to the legislature’s clerk on June 6, 2007, the act swiftly cleared the legislature before the legislative session went into summer recess on June 15, which would not have been possible without consensus among political parties, as the political climate at that time was confrontational.
“The act has benefited the nation. If it hadn’t been passed at that time, it was likely that the biotech and new pharmaceutical industry was doomed,” Wang said today.
Wang said government officials involved in the development of the industry and professionals could corroborate his argument.
“Go ahead and ask them their views on the act,” Wang said.
People can preregister to receive their NT$10,000 (US$325) cash distributed from the central government on Nov. 5 after President William Lai (賴清德) yesterday signed the Special Budget for Strengthening Economic, Social and National Security Resilience, the Executive Yuan told a news conference last night. The special budget, passed by the Legislative Yuan on Friday last week with a cash handout budget of NT$236 billion, was officially submitted to the Executive Yuan and the Presidential Office yesterday afternoon. People can register through the official Web site at https://10000.gov.tw to have the funds deposited into their bank accounts, withdraw the funds at automated teller
PEACE AND STABILITY: Maintaining the cross-strait ‘status quo’ has long been the government’s position, the Ministry of Foreign Affairs said Taiwan is committed to maintaining the cross-strait “status quo” and seeks no escalation of tensions, the Ministry of Foreign Affairs (MOFA) said yesterday, rebutting a Time magazine opinion piece that described President William Lai (賴清德) as a “reckless leader.” The article, titled “The US Must Beware of Taiwan’s Reckless Leader,” was written by Lyle Goldstein, director of the Asia Program at the Washington-based Defense Priorities think tank. Goldstein wrote that Taiwan is “the world’s most dangerous flashpoint” amid ongoing conflicts in the Middle East and Russia’s invasion of Ukraine. He said that the situation in the Taiwan Strait has become less stable
CONCESSION: A Shin Kong official said that the firm was ‘willing to contribute’ to the nation, as the move would enable Nvidia Crop to build its headquarters in Taiwan Shin Kong Life Insurance Co (新光人壽) yesterday said it would relinquish land-use rights, or known as surface rights, for two plots in Taipei’s Beitou District (北投), paving the way for Nvidia Corp to expand its office footprint in Taiwan. The insurer said it made the decision “in the interest of the nation’s greater good” and would not seek compensation from taxpayers for potential future losses, calling the move a gesture to resolve a months-long impasse among the insurer, the Taipei City Government and the US chip giant. “The decision was made on the condition that the Taipei City Government reimburses the related
FRESH LOOK: A committee would gather expert and public input on the themes and visual motifs that would appear on the notes, the central bank governor said The central bank has launched a comprehensive redesign of New Taiwan dollar banknotes to enhance anti-counterfeiting measures, improve accessibility and align the bills with global sustainability standards, Governor Yang Chin-long (楊金龍) told a meeting of the legislature’s Finance Committee yesterday. The overhaul would affect all five denominations — NT$100, NT$200, NT$500, NT$1,000 and NT$2,000 notes — but not coins, Yang said. It would be the first major update to the banknotes in 24 years, as the current series, introduced in 2001, has remained in circulation amid rapid advances in printing technology and security standards. “Updating the notes is essential to safeguard the integrity
RSS